| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/24/2005 | CA2525647A1 Synthetic chemokine receptor ligands and methods of use thereof |
| 02/23/2005 | EP1508620A1 Circular DNA molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 02/23/2005 | EP1508614A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 02/23/2005 | EP1507870A2 Enzymes having dehalogenase activity and methods of use thereof |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507852A2 Nucleic acids and proteins with thioredoxin reductase activity |
| 02/23/2005 | EP1507802A1 Transformed fungi for production of recombinant proteins |
| 02/23/2005 | EP1507799A2 Novel cyclic peptides and use thereof as anti-microbial agents |
| 02/23/2005 | EP1507798A1 Export and modification of (poly)peptides in the lantibiotic way |
| 02/23/2005 | EP1507790A2 Human genes and gene expression products isolated from human prostate |
| 02/23/2005 | EP1507787A2 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms |
| 02/23/2005 | EP1007570A4 Monospecific antibody reactive with fibrinogen and fibrinopeptide b |
| 02/23/2005 | EP0783524B1 Peptides and pharmaceutical compositions comprising them |
| 02/23/2005 | CN1585822A Polycistronic expression of antibodies |
| 02/23/2005 | CN1585778A Modified anti-TNF alpha antibody |
| 02/23/2005 | CN1584044A Preparing method for antler polypeptide or tortoise plastron polypeptide |
| 02/23/2005 | CN1584031A Preparation of effective expressed human DNA enzyme repression factors and their uses in medicines against oxidation and its use against generation of blood vessels |
| 02/23/2005 | CN1584026A Production of oligomeric xylose and special immobilized xylanase therefor |
| 02/23/2005 | CN1584024A Nitrile hydratase and its coding gene and use |
| 02/23/2005 | CN1583171A Preparation of immuno-stimulation composition for hemolycin in monad |
| 02/23/2005 | CN1190499C Collagen preparing process |
| 02/23/2005 | CN1190495C Method for producing heterologous polypeptides in trichothecene-deficient filamentous fungal nutant cells |
| 02/23/2005 | CN1190491C PRV-gene and use thereof |
| 02/23/2005 | CN1190446C New human protein with function of improving mouse NIH/3T3 cell transformation and its encoding sequence |
| 02/22/2005 | US6858775 Method for generating split, non-transferable genes that are able to express an active protein product |
| 02/22/2005 | US6858714 Cyclic GMP phosphodiesterase |
| 02/22/2005 | US6858712 Cloning and expression of HTLV-III DNA |
| 02/22/2005 | US6858704 Oligopeptide sequences with c-terminal acidic tails (ATS); increased stability in enzymes, foods, medicines and chemical products |
| 02/22/2005 | US6858438 Peptides immunoreactive with autoantibodies from patients with rheumatoid arthritis |
| 02/22/2005 | US6858431 An osteoinductive soluble factor induced by the expression of human mineralization protein. |
| 02/22/2005 | US6858416 Human desaturase gene and uses thereof |
| 02/22/2005 | US6858410 Process for making antifusogenic fusion peptides that form inclusion bodies |
| 02/22/2005 | US6858407 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 02/22/2005 | US6858406 Process for the microbial production of amino acids by boosted activity of export carriers |
| 02/22/2005 | US6858405 Process for producing protein hydrolyzate |
| 02/22/2005 | US6858397 Antibodies specific for native PrPsc |
| 02/22/2005 | US6858384 Isolation of bacteriophage from solution; obtain antibody library, incubate with target cells, separate target cell from phage particles, recover phage particles |
| 02/22/2005 | US6858382 Detection systems for registering protein interactions and functional relationships |
| 02/22/2005 | US6858212 Water-soluble yeast extract produced by adding peroxide to growing yeast cells |
| 02/22/2005 | CA2185352C Novel muteins of ifn-.beta. |
| 02/17/2005 | WO2005014848A2 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES |
| 02/17/2005 | WO2005014809A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 02/17/2005 | WO2005014790A2 Polypeptides having oxaloecetate hydrolase activity and polynucleotides encoding same |
| 02/17/2005 | WO2005014788A2 Tssk4: a human testis specific serine/threonine kinase |
| 02/17/2005 | WO2005014779A2 Cyclodextrin affinity purification |
| 02/17/2005 | WO2005014651A1 Sugar chain-modified anti-hm1.24 antibody |
| 02/17/2005 | WO2005014646A1 Method for producing a polypeptide |
| 02/17/2005 | WO2005013912A2 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
| 02/17/2005 | WO2004087730A8 Method for producing diverse libraries of encoded polymers |
| 02/17/2005 | WO2004087044A3 Drug target |
| 02/17/2005 | WO2004083427A3 Ligational encoding of small molecules |
| 02/17/2005 | WO2004074432A3 Antibody vaccine conjugates and uses therefor |
| 02/17/2005 | WO2003091431A8 Methylotroph producing mammalian type sugar chain |
| 02/17/2005 | WO2003050258A3 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2002101013A3 A biological method for the production of alpha-methylene-gamma-butyrolactone and its intermediates |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | WO2002010430A3 Detecting anti-viral drug candidates and resistance |
| 02/17/2005 | US20050037964 Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity |
| 02/17/2005 | US20050037486 Multicompartment apparatus for reformation of functional proteins; bioreactors and protein engineering |
| 02/17/2005 | US20050037464 Prokineticin polypeptides, related compositions and methods |
| 02/17/2005 | US20050037456 Purification of polypeptides |
| 02/17/2005 | US20050037453 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method |
| 02/17/2005 | US20050037448 C-peptide specific assay procedure |
| 02/17/2005 | US20050037444 Method for identification isolation and production of antigens to a specific pathogen |
| 02/17/2005 | US20050037419 Compositions and methods relating to lung specific genes and proteins |
| 02/17/2005 | US20050037412 Thermostable Taq polymerase fragment |
| 02/17/2005 | US20050037411 Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use |
| 02/17/2005 | US20050037392 Optical sorting method |
| 02/17/2005 | US20050037385 Genetically engineered protein comprising multiple zinc finger domains for use as regulatory quadruplets in gene expression analysis |
| 02/17/2005 | US20050037345 Gene with polynucleopotide codes with polypeptide with amino acid sequences for domains and molecular hybridization for gene expression and cancer |
| 02/17/2005 | US20050037336 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 02/17/2005 | US20050037017 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/17/2005 | US20050037014 T helper cell epitopes |
| 02/17/2005 | US20050037005 5c8 Antigen |
| 02/17/2005 | US20050037003 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 02/17/2005 | CA2555323A1 Polypeptide specific to liver cancer, polynucleotide coding for the polypeptide, and rna molecule suppressing expression of the polypeptide |
| 02/17/2005 | CA2534973A1 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
| 02/17/2005 | CA2534899A1 Polypeptides having brain-localizing activity and uses thereof |
| 02/17/2005 | CA2534658A1 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 02/17/2005 | CA2530497A1 Improved electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes |
| 02/17/2005 | CA2528569A1 Method for producing a polypeptide |
| 02/17/2005 | CA2524767A1 Cyclodextrin affinity purification |
| 02/16/2005 | EP1507007A1 Cell cycle related proteins |
| 02/16/2005 | EP1507003A1 Process for producing protein in cell-free protein synthesis system using thioredoxin fused protein expression vector |
| 02/16/2005 | EP1507002A2 Thermostable Taq polymerase fragment |
| 02/16/2005 | EP1506318A2 Methods and compositions for regulation and manipulation of steroidogenesis |
| 02/16/2005 | EP1506317A2 Marker molecules associated with lung tumors |
| 02/16/2005 | EP1506306A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 02/16/2005 | EP1506301A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 02/16/2005 | EP1506298A1 Engineered yeast cells for producing recombinant proteins |
| 02/16/2005 | EP1506286A2 Neutralizing human anti-igfr antibody |
| 02/16/2005 | EP1506215A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 02/16/2005 | EP1506011A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/16/2005 | EP1161548B1 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 02/16/2005 | EP0846160B1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 02/16/2005 | CN1582336A Moraxella (branhamella) catarrhalis antigens |
| 02/16/2005 | CN1582329A New biopesticide using gene from erwinia pyrifoliaeWT#3, novel pathogen that affects asian pear trees |
| 02/16/2005 | CN1582298A High-level composing production for anthrax protection antigen |
| 02/16/2005 | CN1582295A Novel epidermal growth factor protein and gene, and methods of use therefor |